CIK 0001055726
- Non-accelerated filer
- Smaller reporting company
INOVIO PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- INO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330969592
- Phone
- +1 858-410-3134
- Business address
- 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-05 | Weiner David B. Director | Exercise or conversion | +11,667 | 808,777 | ||
| 2020-03-05 | Weiner David B. Director | Exercise or conversion · Restricted Stock Unit | −11,667 | 11,666 | ||
| 2020-03-05 | Kim Jong Joseph Chief Executive Officer | Exercise or conversion | +120,100 | 1,220,807 | ||
| 2020-03-05 | Kim Jong Joseph Chief Executive Officer | Shares withheld for taxes | −37,371 | $9.80 | $366K | 1,183,436 |
| 2020-03-05 | Kim Jong Joseph Chief Executive Officer | Exercise or conversion · Restricted Stock Unit | −120,100 | 120,100 | ||
| 2020-03-05 | Humeau Laurent Chief Scientific Officer | Exercise or conversion | +27,567 | 77,900 | ||
| 2020-03-05 | Humeau Laurent Chief Scientific Officer | Shares withheld for taxes | −9,857 | $9.80 | $97K | 68,043 |
| 2020-03-05 | Humeau Laurent Chief Scientific Officer | Exercise or conversion · Restricted Stock Unit | −27,567 | 27,566 | ||
| 2020-03-05 | KIES PETER CFO | Exercise or conversion | +27,567 | 136,697 | ||
| 2020-03-05 | KIES PETER CFO | Shares withheld for taxes | −9,817 | $9.80 | $96K | 126,880 |
| 2020-03-05 | KIES PETER CFO | Exercise or conversion · Restricted Stock Unit | −27,567 | 27,566 | ||
| 2020-01-15 | Shepard Jay Director | Grant or award · Restricted Stock Unit | +12,821 | 12,821 | ||
| 2020-01-15 | Shepard Jay Director | Grant or award · Common Stock Option | +20,000 | 20,000 | ||
| 2020-01-13 | Kim Jong Joseph Chief Executive Officer | Purchase | +22,500 | $3.11 | $70K | 1,100,707 |
| 2020-01-03 | Zoth Lota S. Director | Exercise or conversion | +4,090 | 4,090 | ||
| 2020-01-03 | Zoth Lota S. Director | Exercise or conversion · Restricted Stock Unit | −4,090 | 8,180 | ||
| 2019-12-05 | YARNO WENDY L Director | Exercise or conversion | +4,090 | 16,350 | ||
| 2019-12-05 | YARNO WENDY L Director | Exercise or conversion · Restricted Stock Unit | −4,090 | 4,090 | ||
| 2019-08-30 | Humeau Laurent Chief Scientific Officer | Purchase | +4,500 | $2.22 | $10K | 50,333 |
| 2019-08-01 | Weiner David B. Director | Sale | −16,352 | $2.72 | $44K | 797,110 |
Page 33 of 49 · 961 trades